Skip to main content
Key Specialties
Anesthesiology Cardiology Dermatology Diabetology Endocrinology Gastroenterology and Hepatology General Medicine Geriatrics Hematology Infectious Diseases Internal Medicine Nephrology Neurology Obstetrics and Gynecology Oncology Ophthalmology Pediatrics Psychiatry Radiology Respiratory Medicine Rheumatology Surgery Urology
Congress Coverage
ASH 2024 Annual Meeting 2024 ESMO Congress 2024 ERS Congress 2024 EASD Congress 2024 ESC Congress 2024 EAN Congress 2024 ASCO Annual Meeting 2024 ACC Congress
Clinical Collections
Women’s Health Knowledge Hub Advances in Alzheimer’s
Video

Keynote series | Spotlight on managing health in obesity

Obesity is a major contributor to cardiorenal metabolic disease, but its impact extends throughout the body. Understand how obesity can affect other organ systems and impact treatment, and whether weight-loss measures improve outcomes.

Launching: Thursday 24th April 2025
 
ADVANCED SEARCH
Log in
Top
Current Pain and Headache Reports
Published in:

26-07-2023 | Gabapentin | Neuropathic Pain (A Abd-Elsayed, Section Editor)

Therapeutic Strategies for Postherpetic Neuralgia: Mechanisms, Treatments, and Perspectives

Authors: Jiayu Tang, Yunchao Zhang, Chenxin Liu, Anqi Zeng, Linjiang Song

Published in: Current Pain and Headache Reports | Issue 9/2023

Login to get access

Abstract

Purpose of Review

Postherpetic neuralgia is an annoying pain that mainly affects older people. In order to give patients more options, this review summarizes the pharmacological and interventional treatments for postherpetic neuralgia and updates the research on the efficacy, thereby providing doctors with more treatment options. The adverse effects and effective doses of its various treatments are also presented so that the therapy can be prescribed according to their concrete physical conditions. In a word, this review is dedicated to providing a comprehensive overview of the treatment options for postherpetic neuralgia and offering patients more choices.

Recent Findings

Combinational therapy is more excellent than monotherapy. The local anesthesia and gabapentin comprised outstanding compatibility. In addition, two therapeutic tools for PHN patients, especially for the intractable ones, electroacupuncture (EA), and osteopathic manipulative treatment (OMT), show their efficacy and become potential options to alleviate pain.

Summary

In terms of treatment, guidelines recommend patients use tricyclic antidepressants (TCAs), gabapentin, pregabalin, and 5% lidocaine patches as the first-line medications, and gabapentin is investigated most, especially the gabapentin enacarbil (GEn). And drug efficacy can be limited by adverse effects and tolerated doses. Interventional treatments, with their invasiveness and operational difficulty, are usually considered for intractable patients. Combinational therapies may be used when a single therapy cannot achieve the desired effect. Therapies such as OMT and EA have also been proposed to palliate pain in some cases, and future directions of treatment may be investigated in Chinese medicine and acupuncture.
Literature
1.
Koshy E, Mengting L, Kumar H, Jianbo W. Epidemiology, treatment and prevention of herpes zoster: a comprehensive review. Indian J Dermatol Venereol Leprol. 2018;84(3):251–62.PubMedCrossRef
2.
3.
Yang F, Yu S, Fan B, Liu Y, Chen YX, Kudel I, et al. The epidemiology of herpes zoster and postherpetic neuralgia in China: results from a cross-sectional study. Pain Ther. 2019;8(2):249–59.PubMedPubMedCentralCrossRef
4.
Johnson RW, Wasner G, Saddier P, Baron R. Postherpetic neuralgia: epidemiology, pathophysiology and management. Expert Rev Neurother. 2007;7(11):1581–95.PubMedCrossRef
5.
Mallick-Searle T, Snodgrass B, Brant JM. Postherpetic neuralgia: epidemiology, pathophysiology, and pain management pharmacology. J Multidiscip Healthc. 2016;9:447–54.PubMedPubMedCentralCrossRef
6.
Baron R, Binder A, Wasner G. Neuropathic pain: diagnosis, pathophysiological mechanisms, and treatment. Lancet Neurol. 2010;9(8):807–19.PubMedCrossRef
7.
Tyring SK. Management of herpes zoster and postherpetic neuralgia. J Am Acad Dermatol. 2007;57(6 Suppl):S136–142.PubMedCrossRef
8.
9.
Hadley GR, Gayle JA, Ripoll J, Jones MR, Argoff CE, Kaye RJ, et al. Post-herpetic neuralgia: a review. Curr Pain Headache Rep. 2016;20(3):17.PubMedCrossRef
10.
Li D, Sun G, Sun H, Wang Y, Wang Z, Yang J. Combined therapy of pulsed radiofrequency and nerve block in postherpetic neuralgia patients: a randomized clinical trial. PeerJ. 2018;6:e4852.PubMedPubMedCentralCrossRef
11.
Patil A, Goldust M, Wollina U. Herpes zoster: a review of clinical manifestations and management. Viruses. 2022;14(2).
12.
Woolf CJ, Max MB. Mechanism-based pain diagnosis: issues for analgesic drug development. Anesthesiology. 2001;95(1):241–9.PubMedCrossRef
13.
Rowbotham MC, Yosipovitch G, Connolly MK, Finlay D, Forde G, Fields HL. Cutaneous innervation density in the allodynic form of postherpetic neuralgia. Neurobiol Dis. 1996;3(3):205–14.PubMedCrossRef
14.
Fields HL, Rowbotham M, Baron R. Postherpetic neuralgia: irritable nociceptors and deafferentation. Neurobiol Dis. 1998;5(4):209–27.PubMedCrossRef
15.
Baron R, Saguer M. Postherpetic neuralgia. Are C-nociceptors involved in signalling and maintenance of tactile allodynia? Brain 1993;116( Pt 6):1477–1496.
16.
17.
18.
Rowbotham MC, Reisner LA, Davies PS, Fields HL. Treatment response in antidepressant-naïve postherpetic neuralgia patients: double-blind, randomized trial. J Pain. 2005;6(11):741–6.PubMedCrossRef
19.
Johnson RW. Herpes zoster and postherpetic neuralgia. Optimal treatment Drugs Aging. 1997;10(2):80–94.PubMedCrossRef
20.
Fashner J, Bell AL. Herpes zoster and postherpetic neuralgia: prevention and management. Am Fam Physician. 2011;83(12):1432–7.PubMed
21.
Saguil A, Kane S, Mercado M, Lauters R. Herpes zoster and postherpetic neuralgia: prevention and management. Am Fam Physician. 2017;96(10):656–63.PubMed
22.
Stankus SJ, Dlugopolski M, Packer D. Management of herpes zoster (shingles) and postherpetic neuralgia. Am Fam Physician. 2000;61(8):2437–2444, 2447–2438.
23.
Kopel J, Brower GL. Effectiveness of pregabalin as a secondary treatment for neuropathic pain from postherpetic neuralgia. Proc (Bayl Univ Med Cent). 2020;33(3):469–70.PubMed
24.
Onakpoya IJ, Thomas ET, Lee JJ, Goldacre B, Heneghan CJ. Benefits and harms of pregabalin in the management of neuropathic pain: a rapid review and meta-analysis of randomised clinical trials. BMJ Open. 2019;9(1):e023600.PubMedPubMedCentralCrossRef
25.
Derry S, Bell RF, Straube S, Wiffen PJ, Aldington D, Moore RA. Pregabalin for neuropathic pain in adults. Cochrane Database Syst Rev. 2019;1:CD007076.
26.
Parsons B, Pan X, Xie L, Chen Y, Ortiz M, Whalen E. Comparison of the efficacy and safety of pregabalin for postherpetic neuralgia in Chinese and international patients. J Pain Res. 2018;11:1699–708.PubMedPubMedCentralCrossRef
27.
Goodman CW, Brett AS. A clinical overview of off-label use of gabapentinoid drugs. JAMA Intern Med. 2019;179(5):695–701.PubMedCrossRef
28.
Bulilete O, Leiva A, Rullán M, Roca A, Llobera J. Efficacy of gabapentin for the prevention of postherpetic neuralgia in patients with acute herpes zoster: a double blind, randomized controlled trial. PLoS ONE. 2019;14(6):e0217335.PubMedPubMedCentralCrossRef
29.
Zhang M, Gao CX, Ma KT, Li L, Dai ZG, Wang S, et al. A meta-analysis of therapeutic efficacy and safety of gabapentin in the treatment of postherpetic neuralgia from randomized controlled trials. Biomed Res Int. 2018;2018:7474207.PubMedPubMedCentral
30.
Wiffen PJ, Derry S, Bell RF, Rice AS, Tölle TR, Phillips T, et al. Gabapentin for chronic neuropathic pain in adults. Cochrane Database Syst Rev. 2017;6(6):Cd007938.
31.
Wang J, Zhu Y. Different doses of gabapentin formulations for postherpetic neuralgia: a systematical review and meta-analysis of randomized controlled trials. J Dermatolog Treat. 2017;28(1):65–77.PubMedCrossRef
32.
Singh D, Kennedy DH. The use of gabapentin for the treatment of postherpetic neuralgia. Clin Ther. 2003;25(3):852–89.PubMedCrossRef
33.
Swearingen D, Aronoff GM, Ciric S, Lal R. Pharmacokinetics of immediate release, extended release, and gastric retentive gabapentin formulations in healthy adults Int J Clin Pharmacol Ther. 2018;56(5):231–8.PubMed
34.
Sang CN, Sathyanarayana R, Sweeney M, Investigators DMS. Gastroretentive gabapentin (G-GR) formulation reduces intensity of pain associated with postherpetic neuralgia (PHN). Clin J Pain. 2013;29(4):281–8.PubMedCrossRef
35.
Irving G. Once-daily gastroretentive gabapentin for the management of postherpetic neuralgia: an update for clinicians. Ther Adv Chronic Dis. 2012;3(5):211–8.PubMedPubMedCentralCrossRef
36.
Backonja MM, Canafax DM, Cundy KC. Efficacy of gabapentin enacarbil vs placebo in patients with postherpetic neuralgia and a pharmacokinetic comparison with oral gabapentin. Pain Med. 2011;12(7):1098–108.PubMedCrossRef
37.
Thomas BM, Farquhar-Smith P. Gabapentin enacarbil extended release for the treatment of postherpetic neuralgia in adults. Ther Clin Risk Manag. 2013;9:469–75.PubMedPubMedCentral
38.
Zhang L, Rainka M, Freeman R, Harden RN, Bell CF, Chen C, et al. A randomized, double-blind, placebo-controlled trial to assess the efficacy and safety of gabapentin enacarbil in subjects with neuropathic pain associated with postherpetic neuralgia (PXN110748). J Pain. 2013;14(6):590–603.PubMedCrossRef
39.
Navez ML, Monella C, Bösl I, Sommer D, Delorme C. 5% Lidocaine medicated plaster for the treatment of postherpetic neuralgia: a review of the clinical safety and tolerability. Pain Ther. 2015;4(1):1–15.PubMedPubMedCentralCrossRef
40.
de León-Casasola OA, Mayoral V. The topical 5% lidocaine medicated plaster in localized neuropathic pain: a reappraisal of the clinical evidence. J Pain Res. 2016;9:67–79.PubMedPubMedCentralCrossRef
41.
42.
Ngo AL, Urits I, Yilmaz M, Fortier L, Anya A, Oh JH, et al. Postherpetic neuralgia: current evidence on the topical film-forming spray with bupivacaine hydrochloride and a review of available treatment strategies. Adv Ther. 2020;37(5):2003–16.PubMedPubMedCentralCrossRef
43.
44.
Laklouk M, Baranidharan G. Profile of the capsaicin 8% patch for the management of neuropathic pain associated with postherpetic neuralgia: safety, efficacy, and patient acceptability. Patient Prefer Adherence. 2016;10:1913–8.PubMedPubMedCentralCrossRef
45.
Derry S, Rice AS, Cole P, Tan T, Moore RA. Topical capsaicin (high concentration) for chronic neuropathic pain in adults. Cochrane Database Syst Rev. 2017;1(1):Cd007393.
46.
Yong YL, Tan LT, Ming LC, Chan KG, Lee LH, Goh BH, et al. The effectiveness and safety of topical capsaicin in postherpetic neuralgia: a systematic review and meta-analysis. Front Pharmacol. 2016;7:538.PubMed
47.
Finnerup NB, Attal N, Haroutounian S, McNicol E, Baron R, Dworkin RH, et al. Pharmacotherapy for neuropathic pain in adults: a systematic review and meta-analysis. Lancet Neurol. 2015;14(2):162–73.PubMedPubMedCentralCrossRef
48.
Falk J, Thomas B, Kirkwood J, Korownyk CS, Lindblad AJ, Ton J, et al. PEER systematic review of randomized controlled trials: management of chronic neuropathic pain in primary care. Can Fam Physician. 2021;67(5):e130–40.PubMedPubMedCentralCrossRef
49.
Chen Z, Shrestha N, Zhao C, Fan B, Luo F. Effect of duloxetine premedication for postherpetic neuralgia within 72 h of herpes zoster reactivation [PROCESS]: a study protocol for a randomized controlled trial. Trials. 2020;21(1):1012.PubMedPubMedCentralCrossRef
50.
Wang D, Lai J, Lu S, Huang M, Hu S, Xu Y. Rapid-onset hyponatremia and delirium following duloxetine treatment for postherpetic neuralgia: case report and literature review. Medicine (Baltimore). 2018;97(46):e13178.PubMedCrossRef
51.
Wen B, Wang Y, Zhang C, Xu W, Fu Z. Efficacy of different interventions for the treatment of postherpetic neuralgia: a Bayesian network meta-analysis. J Int Med Res. 2020;48(12):300060520977416.PubMedCrossRef
52.
Lin CS, Lin YC, Lao HC, Chen CC. Interventional treatments for postherpetic neuralgia: a systematic review. Pain Physician. 2019;22(3):209–28.PubMedCrossRef
53.
Xu G, Xú G, Feng Y, Tang WZ, Lv ZW. Transcutaneous electrical nerve stimulation in combination with cobalamin injection for postherpetic neuralgia: a single-center randomized controlled trial. Am J Phys Med Rehabil. 2014;93(4):287–98.PubMedCrossRef
54.
Stepanovic A, Kolsek M, Kersnik J, Erculj V. Prevention of post-herpetic neuralgia using transcutaneous electrical nerve stimulation. Wien Klin Wochenschr. 2015;127(9–10):369–74.PubMedCrossRef
55.
Chen L, Zhang Y, Chen Y, Wang T, Sun K, Tang H, et al. Efficacy and safety of botulinum toxin A and pulsed radiofrequency on postherpetic neuralgia: a randomized clinical trial. Contrast Media Mol Imaging. 2022;2022:1579937.PubMedPubMedCentral
56.
Kotani N, Kushikata T, Hashimoto H, Kimura F, Muraoka M, Yodono M, et al. Intrathecal methylprednisolone for intractable postherpetic neuralgia. N Engl J Med. 2000;343(21):1514–9.PubMedCrossRef
57.
Texakalidis P, Tora MS, Boulis NM. Neurosurgeons’ armamentarium for the management of refractory postherpetic neuralgia: a systematic literature review. Stereotact Funct Neurosurg. 2019;97(1):55–65.PubMedCrossRef
58.
Zhang Y, Gao YL, Zhang LH. Methylprednisolone and local anesthetic for long-term postherpetic neuralgia: a meta-analysis. J Dermatolog Treat. 2022;33(6):2723–9.PubMedCrossRef
59.
Nguyen DT, Dang TC, Nguyen QA, Le TD, Hoang TD, Tran TNT, et al. The effect of subcutaneous injection of methylprednisolone acetate and lidocaine for refractory postherpetic neuralgia: a prospective, observational study. Health Sci Rep. 2021;4(2):e271.PubMedPubMedCentralCrossRef
60.
Amjad M, Mashhood AA. The efficacy of local infiltration of triamcinolone acetonide with lignocaine compared with lignocaine alone in the treatment of postherpetic neuralgia. J Coll Physicians Surg Pak. 2005;15(11):683–5.PubMed
61.
Ni J, Wang X, Tang Y, Yang L, Zeng Y, Guo Y. Subcutaneous injection of triamcinolone and lidocaine to prevent postherpetic neuralgia. Pain Physician. 2017;20(5):397–403.PubMed
62.
Fan Z, Zheng X, Li D, Chen H, Li L. Comparison of lidocaine and ropivacaine stellate ganglion blockade in treating upper limb postherpetic neuralgia. Medicine (Baltimore). 2022;101(23):e29394.PubMedCrossRef
63.
Brkovic B, Andric M, Calasan D, Milic M, Stepic J, Vucetic M, et al. Efficacy and safety of 1% ropivacaine for postoperative analgesia after lower third molar surgery: a prospective, randomized, double-blinded clinical study. Clin Oral Investig. 2017;21(3):779–85.PubMedCrossRef
64.
Chun-jing H, yi-ran L, hao-xiong N. Effects of dorsal root ganglion destruction by adriamycin in patients with postherpetic neuralgia. Acta Cir Bras. 2012;27(6):404–409.
65.
Huang X, Ma Y, Wang W, Guo Y, Xu B, Ma K. Efficacy and safety of pulsed radiofrequency modulation of thoracic dorsal root ganglion or intercostal nerve on postherpetic neuralgia in aged patients: a retrospective study. BMC Neurol. 2021;21(1):233.PubMedPubMedCentralCrossRef
66.
Lee JB, Byun JH, Choi IS, Kim Y, Lee JS. The effect of pulsed radiofrequency applied to the peripheral nerve in chronic constriction injury rat model. Ann Rehabil Med. 2015;39(5):667–75.PubMedPubMedCentralCrossRef
67.
Ding Y, Hong T, Li H, Yao P, Zhao G. Efficacy of CT guided pulsed radiofrequency treatment for trigeminal postherpetic neuralgia. Front Neurosci. 2019;13:708.PubMedPubMedCentralCrossRef
68.
Han Z, Hong T, Ding Y, Wang S, Yao P. CT-guided pulsed radiofrequency at different voltages in the treatment of postherpetic neuralgia. Front Neurosci. 2020;14:579486.PubMedPubMedCentralCrossRef
69.
Abd-Elsayed A, Kreuger L, Wheeler S, Robillard J, Seeger S, Dulli D. Radiofrequency ablation of pericranial nerves for treating headache conditions: a promising option for patients. Ochsner J. 2018;18(1):59–62.PubMedPubMedCentral
70.
Abd-Elsayed A, Lee S, Jackson M. Radiofrequency ablation for treating resistant intercostal neuralgia. Ochsner J. 2018;18(1):91–3.PubMedPubMedCentral
71.
Fiala KJ, Martens JM, Keith MK, Ghouse A, Abd-Elsayed A. Cooled radiofrequency ablation for intercostal neuralgia. Ochsner Journal. 2023;23(2):159–63.PubMedPubMedCentralCrossRef
72.
Abd-Elsayed A. The ALblation technique for treating migraine headache. Curr Pain Headache Rep. 2020;24(6):29.PubMedCrossRef
73.
Abd-Elsayed A, Falls C, Luo S. Radiofrequency ablation for treating headache: a follow-up study. Curr Pain Headache Rep. 2020;24(4):15.PubMedCrossRef
74.
Abd-Elsayed A, Nguyen S, Fiala K. Radiofrequency ablation for treating headache. Curr Pain Headache Rep. 2019;23(3):18.PubMedCrossRef
75.
76.
Isagulyan E, Slavin K, Konovalov N, Dorochov E, Tomsky A, Dekopov A, et al. Spinal cord stimulation in chronic pain: technical advances. Korean J Pain. 2020;33(2):99–107.PubMedPubMedCentralCrossRef
77.
Dong DS, Yu X, Wan CF, Liu Y, Zhao L, Xi Q, et al. Efficacy of short-term spinal cord stimulation in acute/subacute zoster-related pain: a retrospective study. Pain Physician. 2017;20(5):E633–45.PubMed
78.
Huang J, Yang S, Yang J, Sun W, Jiang C, Zhou J, et al. Early treatment with temporary spinal cord stimulation effectively prevents development of postherpetic neuralgia. Pain Physician. 2020;23(2):E219–30.PubMed
79.
80.
Sun KF, Feng WW, Liu YP, Dong YB, Gao L, Yang HL. Electrical peripheral nerve stimulation relieves bone cancer pain by inducing Arc protein expression in the spinal cord dorsal horn. J Pain Res. 2018;11:599–609.PubMedPubMedCentralCrossRef
81.
Johnson MD, Burchiel KJ. Peripheral stimulation for treatment of trigeminal postherpetic neuralgia and trigeminal posttraumatic neuropathic pain: a pilot study. Neurosurgery. 2004;55(1):135–141; discussion 141–132.
82.
Han R, Guo G, Ni Y, Wang Z, Yang L, Zhang J, et al. Clinical efficacy of short-term peripheral nerve stimulation in management of facial pain associated with herpes zoster ophthalmicus. Front Neurosci. 2020;14:574713.PubMedPubMedCentralCrossRef
83.
Wan CF, Song T. Short-term peripheral nerve stimulation relieve pain for elder herpes zoster ophthalmicus patients: a retrospective study. Neuromodulation. 2021;24(6):1121–6.PubMedCrossRef
84.
Zhao L, Song T. Case report: Short-term spinal cord stimulation and peripheral nerve stimulation for the treatment of trigeminal postherpetic neuralgia in elderly patients. Front Neurol. 2021;12:713366.PubMedPubMedCentralCrossRef
85.
Kim J, Kim MK, Choi GJ, Shin HY, Kim BG, Kang H. Pharmacological and non-pharmacological strategies for preventing postherpetic neuralgia: a systematic review and network meta-analysis. Korean J Pain. 2021;34(4):509–33.PubMedPubMedCentralCrossRef
86.
Volokitin M, Izadi N, Myers R, Kane Diaw N, Milani S. Osteopathic manipulative treatment of herpes zoster ophthalmicus/postherpetic neuralgia. Cureus. 2021;13(5):e14906.PubMedPubMedCentral
87.
Sun R, Li S, Ren L, Xia Y, Wang Y, Bian Z, et al. Efficacy of electroacupuncture for the treatment of postherpetic neuralgia: study protocol for a multicenter randomized controlled trial. J Pain Res. 2022;15:959–68.PubMedPubMedCentralCrossRef
88.
Wu CH, Lv ZT, Zhao Y, Gao Y, Li JQ, Gao F, et al. Electroacupuncture improves thermal and mechanical sensitivities in a rat model of postherpetic neuralgia. Mol Pain. 2013;9:18.PubMedPubMedCentralCrossRef
89.
Zou J, Dong X, Wang K, Shi J, Sun N. Electroacupuncture inhibits autophagy of neuron cells in postherpetic neuralgia by increasing the expression of miR-223-3p. Biomed Res Int. 2021;2021:6637693.PubMedPubMedCentralCrossRef
90.
Wang L, Qiu L, Zheng X, Ouyang J, Zhang M, He L, et al. Effectiveness of electroacupuncture at Jiaji acupoints (EX-B2), plus moxibustion and intermediate on postherpetic neuralgia: a randomized controlled trial. J Tradit Chin Med. 2020;40(1):121–7.PubMed
91.
Pei W, Zeng J, Lu L, Lin G, Ruan J. Is acupuncture an effective postherpetic neuralgia treatment? A systematic review and meta-analysis. J Pain Res. 2019;12:2155–65.PubMedPubMedCentralCrossRef
92.
Hu H, Shen Y, Li X, Tian H, Li X, Li Y, et al. Efficacy of electroacupuncture therapy in patients with postherpetic neuralgia: study protocol for a multicentre, randomized, controlled, assessor-blinded trial. Front Med (Lausanne). 2021;8:624797.PubMedCrossRef
93.
Barbarisi M, Pace MC, Passavanti MB, Maisto M, Mazzariello L, Pota V, et al. Pregabalin and transcutaneous electrical nerve stimulation for postherpetic neuralgia treatment. Clin J Pain. 2010;26(7):567–72.PubMedCrossRef
94.
Jin YY, Qin CH, Duan BL, Huang YQ, Ma K. Clinical efficacy of bulleyaconitine A combined with gabapentin on postherpetic neuralgia. Zhonghua Yi Xue Za Zhi. 2021;101(43):3575–80.PubMed
95.
Wang C, Yuan F, Cai L, Lu H, Chen G, Zhou J. Ultrasound-guided stellate ganglion block combined with extracorporeal shock wave therapy on postherpetic neuralgia. J Healthc Eng. 2022;2022:9808994.PubMedPubMedCentral
96.
Huang S, Xu Y, Pan Z, Li Z, Luo R, Yu M, et al. Efficacy and safety of fire needle combined with cupping for acute herpes zoster and postherpetic neuralgia: a protocol for systemic review and meta-analysis. Medicine (Baltimore). 2022;101(50):e32251.PubMedCrossRef
97.
Zhang JF, Williams JP, Zhao QN, Liu H, An JX. Combined high-voltage pulsed radiofrequency and ozone therapy versus ozone therapy alone in treating postherpetic neuralgia: a retrospective comparison. Med Gas Res. 2023;13(1):15–22.PubMedCrossRef
Metadata
Title
Therapeutic Strategies for Postherpetic Neuralgia: Mechanisms, Treatments, and Perspectives
Authors
Jiayu Tang
Yunchao Zhang
Chenxin Liu
Anqi Zeng
Linjiang Song
Publication date
26-07-2023
Publisher
Springer US
Published in
Current Pain and Headache Reports / Issue 9/2023
Print ISSN: 1531-3433
Electronic ISSN: 1534-3081
DOI
https://doi.org/10.1007/s11916-023-01146-x

Other articles of this Issue 9/2023

Peripheral Nerve Stimulation for Pain Management: A Review

The Exploration of Cannabis and Cannabinoid Therapies for Migraine

  • Migraine
  • Non-pharmacologic Aspects of Pain, Migraine, and Headache (D Buse, Section Editor)

Acupuncture for Low Back Pain: Reevaluation of Systematic Reviews and Meta-analyses

  • Open Access
  • Acupuncture
  • Alternative Treatments for Pain Medicine (M Jones, Section Editor)

The Acute Perioperative Pain Service: Impact, Organization, and Future Directions

  • Opioids
  • Acute Pain Medicine (R Urman, Section Editor)

A Multimodal Conservative Approach to Treating Migraine: A Physical Therapist’s Perspective

  • Migraine
  • Non-pharmacologic Aspects of Pain, Migraine, and Headache (D Buse, Section Editor)

Acute Pain and Development of Opioid Use Disorder: Patient Risk Factors

  • Open Access
  • Opioids
  • Acute Pain Medicine (R Urman, Section Editor)